Biologics in patients with skin diseases

    loading  Checking for direct PDF access through Ovid

Abstract

Biologic agents are important therapeutic options for treating multiple moderate-to-severe cutaneous diseases. Monoclonal antibodies already in use or under investigation are targeted for psoriasis, atopic dermatitis, melanoma, hidradenitis suppurativa, and pemphigus vulgaris.

Related Topics

    loading  Loading Related Articles